Latest Biosimilar Stories
Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.
LONDON, Feb. 16, 2015 /PRNewswire/ -- The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S.
SAN DIEGO, Feb. 13, 2015 /PRNewswire/ -- Pfenex Inc.
MUMBAI, February 12, 2015 /PRNewswire/ -- Date Info: 10 Mar 2015 to 11 Mar 2015 Venue Info: The Kensington Close Hotel, Wrights Lane, London, UK
CRANBURY, N.J., Feb.
LONDON, February 11, 2015 /PRNewswire/ -- Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors,
BCC Research (http://www.bccresearch.com) reveals in its new report on antibody drugs that increasing competition and new technologies are
SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.
DUBLIN, Feb .04, 2015 /PRNewswire/ --Research and Markets
Primary Efficacy Analysis Demonstrates Clinical Equivalence THOUSAND OAKS, Calif., Feb.
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.